"Founded in 2011, the Orlando Epilepsy Center team consists of highly skilled Neurology providers who specialize in seizure and epilepsy diagnosis, treatment, and management."

During the past decade, Neurology and Epilepsy Research Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neurology and Epilepsy Research Center" are "Dravet Syndrome" (2 trials) and "Seizure Disorder" (1 trials). Many other conditions were trialed in "Neurology and Epilepsy Research Center" in a lesser frequency.

Most popular intervention types in "Neurology and Epilepsy Research Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ZX008 (Fenfluramine Hydrochloride)" (2 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology and Epilepsy Research Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neurology and Epilepsy Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurology and Epilepsy Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurology and Epilepsy Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".